Global Neurodiagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Technology;

Neuroimaging Technologies, In Vitro Diagnostics, and Neuro Informatics

By Product;

Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), and Reagents & Consumables

By Therapeutic Area;

Neurodegenerative Diseases, Sleep Disorders, Stroke, Epilepsy, and Others

By End Use;

Hospitals and Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn912124437 Published Date: May, 2025 Updated Date: June, 2025

Neurodiagnostics Market Overview

Neurodiagnostics Market (USD Million)

Neurodiagnostics Market was valued at USD 7,922.53 million in the year 2024. The size of this market is expected to increase to USD 13,316.00 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.7%.


Global Neurodiagnostics Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 7.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.7 %
Market Size (2024)USD 7,922.53 Million
Market Size (2031)USD 13,316.00 Million
Market ConcentrationMedium
Report Pages306
7,922.53
2024
13,316.00
2031

Major Players

  • Canon Medical Systems Corporation
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Thermo Fisher Scientific, Inc.
  • FUJIFILM Corporation
  • Natus Medical Incorporated (Natus)
  • Lifelines Neuro
  • Advanced Brain Monitoring, Inc.
  • NIHON KOHDEN CORPORATION.
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare.
  • Mitsar Co. LTD.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Neurodiagnostics Market

Fragmented - Highly competitive market without dominant players


The Neurodiagnostics Market is witnessing strong momentum, primarily fueled by the increasing burden of neurological conditions and the emphasis on early diagnosis. Disorders such as epilepsy, Alzheimer’s, and Parkinson’s are becoming more common, leading to a higher demand for precise and timely testing. Over 60% of diagnostic decisions in neurology now involve neurodiagnostic technologies, emphasizing their critical role in patient care.

Innovation Driving Market Transformation
Advancements in non-invasive neuroimaging and electrophysiological monitoring are redefining diagnostic practices. Emerging tools, including EEG, MEG, and functional MRI, are increasingly incorporating AI-based enhancements, improving speed and accuracy. Notably, about 40% of new diagnostic equipment in this space features AI capabilities, aligning with the need for smarter clinical workflows.

Focus on Early Detection and Intervention
Healthcare systems are placing a stronger focus on early identification of neurological disorders, significantly impacting diagnostic approaches. Nearly 55% of neurological assessments now incorporate neurodiagnostic evaluations at the first point of care, reflecting a shift toward proactive treatment planning and improved outcomes.

Preventive Integration into General Healthcare
Neurodiagnostics is becoming a staple of preventive healthcare programs, especially in specialized and tertiary clinics. Close to 35% of comprehensive health screenings now include neurological assessments, reflecting an expanding role in routine preventive care and brain health maintenance.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By Product
    3. Market Snapshot, By Therapeutic Area
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Neurodiagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advancements In Neuroimaging And Diagnostic Tools
        2. Increasing Demand For Early Disease Detection
        3. Growing Adoption Of Non-Invasive Procedures
      2. Restraints
        1. Limited Access In Underdeveloped Regions
        2. Lack Of Skilled Neurology Professionals
        3. Complex Regulatory And Approval Procedures
      3. Opportunities
        1. Expansion In Emerging Healthcare Markets
        2. Telehealth And Remote Neurodiagnostic Services
        3. Development Of Portable Brain Monitoring Devices
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Neurodiagnostics Market, By Technology, 2021 - 2031 (USD Million)
      1. Neuroimaging Technologies
      2. In Vitro Diagnostics
      3. Neuro informatics
    2. Neurodiagnostics Market, By Product, 2021 - 2031 (USD Million)
      1. Diagnostic & Imaging Systems
        1. MRI
        2. Ultrasound
      2. Clinical Testing
        1. PCR
        2. NGS
      3. Reagents & Consumables
    3. Neurodiagnostics Market, By Therapeutic Area, 2021 - 2031 (USD Million)
      1. Neurodegenerative Diseases
      2. Sleep Disorders
      3. Stroke
      4. Epilepsy
      5. Others
    4. Neurodiagnostics Market, ByEnd Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
    5. Neurodiagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Canon Medical Systems Corporation
      2. Siemens Healthineers AG
      3. Koninklijke Philips N.V.
      4. Thermo Fisher Scientific, Inc.
      5. FUJIFILM Corporation
      6. Natus Medical Incorporated (Natus)
      7. Lifelines Neuro
      8. Advanced Brain Monitoring, Inc.
      9. NIHON KOHDEN CORPORATION.
      10. F. Hoffmann-La Roche Ltd
      11. GE HealthCare.
      12. Mitsar Co. LTD.
  7. Analyst Views
  8. Future Outlook of the Market